In Autoimmune Disease, Finding Clarity Beyond the Genome: Stefan Muellner, Protagen
Myriad Settlements Mark End of an Era: Antoinette Konski on Gene Patents
David Schwartz on the Future of Sequencing
Not a Stenographer to Power: Luke Timmerman and the New 'Timmerman Report'
FDA Will Take Time to Digest Comments on LDT Guidance, Says Liz Mansfield
Future of Personalized Medicine at Stake, says Amy Miller of PMC about LDT Regulation
'A Good Year' with John LaMattina
An Exciting Time for Mass Spec: Paul Beresford, Biodesix
Current Version of LDT Draft Guidance Means Much Fewer and Lower Quality Tests for Patients, Says Elaine Lyon of ARUP
The Sad State of Biospecimen Science with David Rimm, Yale
Cancer 2014: The Year in Review with Anna Barker
Faces of Leadership in Diagnostics: Surbhi Sarna
Historic Consensus Reached on Biospecimen Standards: Carolyn Compton, NBDA
Setting Better Expectations for Genomic Medicine: Geoff Ginsburg, Duke University
Test Driving Genomic Medicine: Thomas Quertermous, Stanford
The Silicon Valley Fantasy Trip: Sci-fi Author Kim Stanley Robinson Talks Life Science
Faces of Leadership in Diagnostics: Mara Aspinall
The Daunting Task of Managing Biospecimens at the World's Largest CRO: Diane Farhi, Quintiles
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
Biosampling Basics with Scott Jewell, Van Andel Institute
Create your
podcast in
minutes
It is Free
Sasquatch Chronicles
The Confessionals
Radiolab
Sasquatch Odyssey
Bigfoot and Beyond with Cliff and Bobo